ClinicalTrials.gg
CompletedNCT01210807Updated Feb 4, 2025Results posted

Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL)

A Phase 4 interventional study of One-Piece Tecnis Multifocal IOL and One-Piece Tecnis monofocal IOL, Model ZCB00 in Cataract, sponsored by Abbott Medical Optics. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-04.

Sponsored by Abbott Medical Optics (formerly part of Abbott) · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate near vision of the One-Piece Tecnis Multifocal lens (ZMB00) vs. the One-piece Tecnis monofocal lens (ZCB00)and additionally evaluate general postoperative outcomes of the One-Piece Tecnis Multifocal lens.

02

Conditions studied

  • Cataract

Browse trials for

03

In context

Cataract

1,726 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's enrollment of 70 is below the median of 80 across 1,171 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Abbott Medical Optics is the lead sponsor of 35 studies on the registry; none are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 7 (100%) have results posted.

First submitted before Abbott Medical Optics left Abbott.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • bilateral cataracts and otherwise healthy eyes
  • visual potential of Decimal 0.8 in each eye

Exclusion criteria

Exclusion Criteria:

  • any medications affecting vision
  • any chronic disease/illness that would affect risk to subject or outcomes of the study
  • any ocular pathology/abnormalities that may affect visual outcomes or confound study results
  • desire for monovision
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Multifocal Intraocular Lens

    ZMB00 multifocal intraocular lens

    Device: One-Piece Tecnis Multifocal IOL

  • Active comparator
    Monofocal Intraocular Lens

    ZCB00 monofocal intraocular lens

    Device: One-Piece Tecnis monofocal IOL, Model ZCB00

Interventions

  • DeviceOne-Piece Tecnis Multifocal IOL

    One-piece Tecnis Multifocal IOL, Model ZMB00, implanted lens.

    Also known as: Model ZMB00

  • DeviceOne-Piece Tecnis monofocal IOL, Model ZCB00

    Control lens: One-Piece Tecnis monofocal IOL, Model, ZCB00, implanted lens.

    Also known as: ZCB00

06

What researchers measure

Primary outcomes

  1. Mean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm

    Snellen equivalent for the mean logMAR binocular photopic distance corrected near visual acuity at 33 cm is 20/24 for the Multifocal Group. Snellen equivalent for the mean logMAR binocular photopic distance corrected near visual acuity at 33 cm is 20/81 for the Monofocal Group.

    Time frame: 4-6 Months

Secondary outcomes

  1. Number of Subjects With 20/40 or Better Best Corrected Binocular Distance Visual Acuity

    Time frame: 4-6 months

07

Results

Posted Dec 13, 2013

Participant flow

Participant flow — Overall Study
MilestoneZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular Lens
Started3634
Completed3331
Not completed33
Withdrew: Lost to follow-up12
Withdrew: Not implanted bilaterally21

Outcome measures

SecondaryNumber of Subjects With 20/40 or Better Best Corrected Binocular Distance Visual Acuity
Time frame:
4-6 months
Reported as:
Number · participants
Number of Subjects With 20/40 or Better Best Corrected Binocular Distance Visual Acuity
participantsZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular Lens
Number of Subjects With 20/40 or Better Best Corrected Binocular Distance Visual Acuity3231
PrimaryMean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm

Snellen equivalent for the mean logMAR binocular photopic distance corrected near visual acuity at 33 cm is 20/24 for the Multifocal Group. Snellen equivalent for the mean logMAR binocular photopic distance corrected near visual acuity at 33 cm is 20/81 for the Monofocal Group.

Time frame:
4-6 Months
Reported as:
Mean · logMAR visual acuity
Mean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm
logMAR visual acuityZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular Lens
Mean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm0.07 ± 0.120.61 ± 0.15

Adverse events

Non-serious events are listed at a 2% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ZMB00 Multifocal Intraocular Lens—0/36 (0%)3/36 (8.3%)
ZCB00 Monofocal Intraocular Lens—0/34 (0%)4/34 (11.8%)
Most frequent other events
Most frequent other events
EventZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular Lens
Macular edemaEye disorders1/361/34
IOL replacement secondary to broken haptic during surgeryEye disorders0/361/34
Wound leakageEye disorders0/361/34
Head and shoulder injury secondary to wheelchair malfunctionInjury, poisoning and procedural complications0/361/34
Vitreous detachmentEye disorders1/360/34
Head injury secondary to car accidentInjury, poisoning and procedural complications1/360/34

Baseline characteristics

A total of 34 ZMB00 multifocal and 33 ZCB00 monofocal subjects were implanted bilaterally. Data analysis for baseline characteristics was completed on these 67 subjects.

Age, Continuous
Age, Continuous(years)ZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular LensTotal
Mean63.1 ± 11.468.3 ± 11.365.9 ± 11.6
Sex: Female, Male
Sex: Female, Male(Participants)ZMB00 Multifocal Intraocular LensZCB00 Monofocal Intraocular LensTotal
Female231740
Male111627
08

Study locations

No study locations are listed for this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01210807
Responsible party
Sponsor
First posted
Sep 29, 2010
Start date
Nov 2009
Primary completion
Aug 2011
Completion
Aug 2011
Results posted
Dec 13, 2013
Last update
Feb 4, 2025

Study contacts

Peter Szurman, PD Dr. med.
principal investigator

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion